Endowed Professorship in Cancer Therapeutics (002380-2010)
Requirements: The Department of Medicinal Chemistry and Molecular Pharmacology in the College of Pharmacy and the Purdue University Center for Cancer Research invite applications from individuals with a distinguished record of accomplishment to fill an endowed chair in Cancer Therapeutics that the rank of Full Professor. We are particularly interested in candidates who apply techniques and approaches emerging from the chemistry-biology interface or nanoscience to the discovery, development, and/or delivery of cancer therapies.
The Department provides a unique interdisciplinary environment offering investigators unparalleled opportunities to work with colleagues whose research programs are focused in medicinal chemistry and chemical biology, molecular and cellular biology, molecular pharmacology, biophysical & computational chemistry, and systems biology & functional genomics. The Department is closely linked with the Purdue University Center for Cancer Research and its four program areas, Cell Growth and Differentiation, Chemical and Structural Biology, Medicinal Chemistry, and Drug Delivery and Molecular Sensing. The Center is among an elite group of sixty-six Cancer Centers nationwide to earn the distinguished National Cancer Institute (NCI) designation, and is one of just seven NCI-designated basic-research Cancer Centers in the United States. The Center also provides outstanding shared resources to support both chemical and biological research endeavors. Finally, it should be noted that both the Department and the Center offer exceptionally collegial and collaborative research environments.
As a part of a larger multidisciplinary vision at Purdue, the University has embarked on a new research endeavor, Discovery Park, which has provided several centers (housed in seven new buildings) dedicated to cutting-edge multidisciplinary research efforts. One of these centers, the Bindley Bioscience Center, is dedicated to the support of multidisciplinary research at the intersection of biology, chemistry, and engineering, and provides world-class facilities in such areas as cytomics and proteomics to the wider Purdue community. A new wing for the Bindley Bioscience Center, funded through and NIH stimulus grant, will provide enhanced, cutting edge capabilities in animal models and in vivo imaging for cancer therapeutics research. The Birck Nanotechnology Center provides world-class facilities in this area, including bionanotechnology, and provides a nexus for Purdue¡¯s strong research efforts at the biology/engineering interface. Faculty in the Cancer Center are also key participants in other research centers on campus, in particular the Markey Center for Structural Biology, housed in a new structural biology building in Discovery Park, and the Oncological Sciences Center. Discovery Park also provides links to transition successful discovery programs to the commercial sector, through the Burton Morgan Center and the Mann Institute. Purdue efforts in the commercial arena are directed through Purdue Research Park and the Office of Technology Commercialization. The NIH-funded Indiana Clinical and Translational Sciences Institute provides a nexus for translational research in therapeutics, bringing together basic and clinical research efforts from Purdue, Notre Dame, and Indiana University. The successful applicant for this chair will also have the opportunity to participate in the newly founded Purdue Drug Discovery Institute which will provide key support in this area (including a new drug discovery building).
Application: Applicants should send a curriculum vita, a brief summary of research accomplishments and of ongoing research, to:
Head of Cancer Therapeutics Search
Purdue University, MCMP
575 Stadium Mall Dr
West Lafayette, IN
Applications will be reviewed beginning October 15, 2010 and will continue until the position is filled.